Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

May 13, 2014 7:35am EDT

Heat Biologics, Inc. Reports 2014 First Quarter Financial Results

Apr 09, 2014 12:00pm EDT

Heat Biologics, Inc. Presents Proprietary Allogeneic Cell Line Antigen Screening Algorithm and Systematic Analysis of Combination Tumor Immunotherapy Preclinical Data at the 105th Annual Meeting of the American Association for Cancer Research

Apr 01, 2014 7:35am EDT

Heat Biologics, Inc. Reports 2013 Fourth Quarter and Full Year Financial Results

Mar 26, 2014 4:15pm EDT

Heat Biologics, Inc. to Present at the MaidStone Life Sciences Fourth Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference on Thursday, March 27, 2014

Mar 19, 2014 8:00am EDT

Heat Biologics, Inc. Submits Revised Protocol to FDA for Phase 2 Clinical Study of HS-110 for the Treatment of Non-Small Cell Lung Cancer

Mar 10, 2014 8:05am EDT

Heat Biologics, Inc. Presents Preclinical Data From Comparative Combination Cancer Immunotherapy Research Study at Keystone Symposia on Immune Evolution in Cancer

Mar 05, 2014 8:05am EST

Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development

Mar 03, 2014 8:05am EST

Heat Biologics Commences Dosing of First Patient in Phase 1/2 Study of Novel Cancer Immunotherapy Product Candidate HS-410 for the Treatment of Bladder Cancer

Feb 04, 2014 8:05am EST

Heat Biologics, Inc. to Present at 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014

Feb 03, 2014 8:35am EST

Heat Biologics, Inc. Announces Formation of Clinical Advisory Board With Preeminent Immunotherapy and Oncology Experts

rss_feed News RSS